Exin Therapeutics uses AI agent for mouse brain surgery
Biotech startup Exin Therapeutics announced it successfully performed a brain surgery on a mouse using an AI agent. The team used the Anthropic Sonnet model to autonomously select the drug, dosage, and brain region, operating a robotic arm to inject medication for epilepsy. The experiment highlights AI's potential in neural therapy, with veterinary supervision and an emergency stop mechanism in place.
Summarized by AI from one outlet
Source
- IT之家Read original ↗
Latest
- Research
AI models show prompt order bias in trolley problem
A study tested 14 AI models on the trolley problem, finding that simply changing the order of prompts caused some models to prioritize saving a server over human lives. This result reveals an attention bias in AI regarding word order, raising concerns about the stability of safety alignment and value judgments.
- Research
Semi-Adversarial Training for AI Therapy
A study on AI mental health applications proposes a semi-adversarial training method to make interactions between AI therapists and clients more realistic. The approach aims to overcome limitations of traditional collaborative training to enhance AI assistance in counseling scenarios.
- Research
Discussion on AI Text Watermarking and Quality Loss
The Hacker News community discusses the impact of AI text watermarking on generated content quality. The topic focuses on how to mark AI-generated content while maintaining text readability and quality.
- Research
Study on Generative AI's Impact on Critical Thinking (2025)
A 2025 study examines the impact of generative AI on users' critical thinking. The research relies primarily on self-reported data to analyze how AI tools alter cognitive patterns and decision-making processes.
- Research
Arca Discusses AI Agents for Long-Horizon Financial Work
The head of AI at Arca discussed persistent memory, the benefits of a custom harness, and agentic workflows spanning days for long-horizon financial work on Latent Space.
All news → · All rights belong to the original creators